Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Grants
$54k
1 grant · CORDIS
Backers
1
LIOF
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 1, 2018 Won a grant $54k · CORDIS
Funding rounds
RoundDateAmountInvestorsSource
Grant Dec 2018 $54k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Curevo Vaccine51-200 employees
Curevo Vaccine is a clinical-stage biotech company dedicated to developing next-generation adjuvanted subunit vaccines to the market…
Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets…
DeepflareFounded 2020
Deepflare predicts true T-cell immunogenicity with 12x greater accuracy than standard tools. Design next-generation antigen candidates for…
ReNewVax logoFounded 2022
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
BaseimmuneSeries A $11.3M · 2 yr ago • Founded 2019 • 11-50 employees
404 Err….or The vaccines you're looking for don't exist. Yet….
GIVAX51-200 employees
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…

Overview

Clinical Phase 2 Study - BE RESPONDER!. Cytuvax has completed the Phase 2 BE RESPONDER! clinical study to investigate the immunogenicity and safety of its Hepatitis B HBAI20 vaccine for Non-responders.

News

News pharmabiz.com 10 years ago
CyTuVax reports positive interim results from phase I study of HBAI20 hepatitis B vaccine for non-responders
CyTuVax reports positive interim results from phase I study of HBAI20 hepatitis B vaccine for non-responders
Read more
Report

Financials

Total raised
$54k
Latest round
Grant
Funding rounds
1
Funding rounds
Round Announced Amount
Grant 2018 $54k Details